602 related articles for article (PubMed ID: 16784126)
21. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L
New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
[TBL] [Abstract][Full Text] [Related]
22. [Frequency and antifungal profile of Candida isolated from vaginal exudates of preadolescent girls].
Giusiano G; Rojas F; Toma-Vanacore S; Mangiaterra M
Enferm Infecc Microbiol Clin; 2009; 27(7):428. PubMed ID: 19403204
[No Abstract] [Full Text] [Related]
23. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
24. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
Abu-Elteen KH
Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
[TBL] [Abstract][Full Text] [Related]
25. [Vaginal candida infection in the third trimester of pregnancy].
Nikolov A; Shopova E; Mŭseva A; Dimitrov A
Akush Ginekol (Sofiia); 2006; 45(6):7-9. PubMed ID: 17168476
[TBL] [Abstract][Full Text] [Related]
26. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and phenotypic evaluation of Candida dubliniensis in pregnant women with vulvovaginal candidosis in a university hospital in Ankara.
Us E; Cengiz SA
Mycoses; 2007 Jan; 50(1):13-20. PubMed ID: 17302742
[TBL] [Abstract][Full Text] [Related]
28. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
[TBL] [Abstract][Full Text] [Related]
29. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
Nawrot U; Nowicka J; Juszczak K; Gusin B
Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
[TBL] [Abstract][Full Text] [Related]
33. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
34. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
35. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Yan Z; Young AL; Hua H; Xu Y
J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
Brandão LDS; Boniek D; Resende Stoianoff MA; da Mata FMR; de Azevedo PRM; Fernandes JV; Andrade VS
Lett Appl Microbiol; 2018 Sep; 67(3):285-291. PubMed ID: 29908032
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
[TBL] [Abstract][Full Text] [Related]
40. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
